Specific and pronounced impacts of lisinopril and lisinopril plus simvastatin on erythrocyte antioxidant enzymes

Journal of Clinical Pharmacology

Volumn 50, Issue 2, 2010, Pages 180-187

  Kaminsky, Yury ^a   Suslikov, Alexander ^b   Kosenko, Elena ^a  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^b RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

Antioxidant enzymes; Erythrocyte; Lisinopril; Simvastatin

Indexed keywords

6 PHOSPHOFRUCTOKINASE; CATALASE; CHOLESTEROL; ERYTHROCYTE ENZYME; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LACTATE DEHYDROGENASE; LISINOPRIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTENSION; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL, LDL; DRUG SYNERGISM; ENERGY METABOLISM; ERYTHROCYTES; FEMALE; HUMANS; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXIDOREDUCTASES; RANDOM ALLOCATION; SIMVASTATIN;

EID: 75749101030     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009344854     Document Type: Article

References (29)

1. Sp3sito AC, Mansur AP, Coelho OR, Nicolau JC, Ramires JA Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril). Am J Cardiol. 1999 ; 83: 1497-1499.
2. Ledingham JM, Laverty R. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model. Clin Exp Pharmacol Physiol. 2005 ; 32: 76-85.
3. Chopra V., Choksi PU, Cavusoglu E. Beyond lipid lowering: the anti-hypertensive role of statins. Cardiovasc Drugs Ther. 2007 ; 21: 161-169.
4. Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta. 2001 ; 306: 1-17.
5. John S., Schmieder RE Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep. 2003 ; 5: 199-207.
6. Brzeszczynska J., Pieniazek A., Gwozdzinski L., Gwozdzinski K., Jegier A. Structural alterations of erythrocyte membrane components induced by exhaustive exercise. Appl Physiol Nutr Metab. 2008 ; 33: 1223-1231.
7. Hamilton CA, Miller WH, Al- Benna S., et al. Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond). 2004 ; 106: 219-234.
8. Broncel M., Koter-Michalak M., Chojnowska-Jezierska J. The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia. Przegl Lek. 2006 ; 63: 738-742.
9. Broncel M., BaÅa A., Koter-Michalak M., Duchnowicz P., Wojsznis W., Chojnowska-Jezierska J. Physicochemical modifications induced by statins therapy on human erythrocytes membranes. Wiad Lek. 2007 ; 60: 321-328.
10. Fernandes AC, Filipe PM, Freitas JP, Manso CF Different effects of thiol and nonthiol ace inhibitors on copper-induced lipid and protein oxidative modification. Free Radic Biol Med. 1996 ; 20: 507-514.
11. Kosenko E., Kaminsky Y., Kaminsky A., et al. Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic Res. 1997 ; 27: 637-644.
12. Kosenko EA, Venediktova NI, Kudryavtsev AA, et al. Encapsulation of glutamine synthetase in mouse erythrocytes: a new procedure for ammonia detoxication. Biochem Cell Biol. 2008 ; 86: 469-476.
13. Kaminsky YG, Kosenko EA Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo. Free Radic Res. 2008 ; 42: 564-573.
14. Kosenko EA, Solomadin IN, Kaminsky YuG. Effect of the b-amyloid peptide Ab25-35 and fullerene C60 on the activity of enzymes in erythrocytes. Russ J Bioorg Chem. 2009;35:157-162.
15. Ager A, Gordon JL. Differential effects of hydrogen peroxide on indices of endothelial cell function. J Exp Med. 1984;159: 592-603.
16. Rubin R., Farber JL Mechanism of the killing of cultured hepatocytes by hydrogen peroxide. Arch Biochem Biophys. 1984 ; 228: 450-459.
17. Simon RH, Scoggin CH, Patterson D. Hydrogen peroxide causes the fatal injury to human fibroblasts exposed to oxygen radicals. J Biol Chem. 1981 ; 256: 7181-7186. (Pubitemid 11021803)
18. Djordjevi VB, Pavlovi D., Pejovi M., Cvetkovi T., Leci N., Deljanin-Ili M. Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors. Clin Nephrol. 1997 ; 47: 243-247.
19. Djordjevi VB, Grubor-Lajsi G., Jovanovic-Galovi A., Pavlovi D., Cvetkovi T., Pejovi M., Leci N. Selenium-dependent GSH-Px in erythrocytes of patients with hypertension treated with ACE inhibitors. J Environ Pathol Toxicol Oncol. 1998 ; 17: 277-280.
20. de Cavanagh EM, Ferder L., Carrasquedo F., et al. Higher levels of antioxidant defenses in enalapril-treated versus non-enalapril-treated hemodialysis patients. Am J Kidney Dis. 1999 ; 34: 445-455.
21. Khan BV, Sola S., Lauten WB, et al. Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome. Diabetes Care. 2004 ; 27: 1712-1715.
22. de Cavanagh EM, Fraga CG, Ferder L., Inserra F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol. 1997 ; 272: R514 - R518.
23. de Cavanagh EM, Inserra F., Ferder L., Fraga CG Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol Regul Integr Comp Physiol. 2000 ; 278: R572 - R577.
24. Djordjevic VB, Cosic V., Pavlovic D., et al. Does captopril change oxidative stress in puromycin aminonucleoside nephropathy ? Ren Fail. 2000 ; 22: 535-544.
25. Kowalski J., Pawlicki L., Grycewicz J., et al. Estimation of antioxidative effect of atorvastatin and fluvastatin used in primary prevention of coronary heart disease-effect on antioxidative enzymatic activity. Wiad Lek. 2005 ; 58: 275-279.
26. Sola S., Mir MQ, Lerakis S., Tandon N., Khan BV Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol. 2006 ; 47: 332-337.
27. Kowalski J., Olejniczak J., BÅaszczyk J., et al. Effect of fluvastatin and fenofibrate on the antioxidative barrier enzyme activity in patients with dyslipidemia. Pol Merkur Lekarski. 2003 ; 14: 285-288. (Pubitemid 36542028)
28. Passi S., Stancato A., Aleo E., Dmitrieva A., Littarru GP Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors. 2003 ; 18: 113-124.
29. Giulivi C., Hochstein P., Davies Kja. Hydrogen peroxide production by red blood cells. Free Radic Biol Med. 1994 ; 16: 123-129.